March 14 (Reuters) - Reckitt RKT.L said on Friday a circuit court in the United States had ruled that a new trial could be sought by plaintiffs in a case that accused the London-listed firm and Abbott ABT.N of failing to warn of the risks of premature-infant formulas.
The Thursday's ruling comes after a St. Louis, Missouri state court last October found Reckitt unit Mead Johnson and Abbott not responsible for a young boy's debilitating intestinal disease.
(Reporting by Aby Jose Koilparambil in Bengaluru; Editing by Anil D'Silva)
((abyjose.koilparambil@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.